| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.443 | 1.613 | 867 | 3.351 | 3.981 | 731 | 415 | 0 | - | - |
| Total Income - EUR | 5.443 | 1.613 | 876 | 3.393 | 4.000 | 737 | 421 | 33 | - | - |
| Total Expenses - EUR | 4.171 | 3.181 | 2.891 | 2.884 | 1.609 | 397 | 879 | 71 | - | - |
| Gross Profit/Loss - EUR | 1.272 | -1.568 | -2.015 | 509 | 2.391 | 340 | -458 | -38 | - | - |
| Net Profit/Loss - EUR | 1.110 | -1.616 | -2.041 | 409 | 2.271 | 318 | -471 | -38 | - | - |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | - | - |
Check the financial reports for the company - Ilomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 914 | 646 | 381 | 125 | 0 | 0 | 0 | 0 | - | - |
| Current Assets | 11.513 | 11.802 | 10.933 | 12.178 | 8.812 | 9.079 | 8.278 | 8.266 | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Receivables | 320 | 317 | 312 | 306 | 310 | 604 | 288 | 289 | - | - |
| Cash | 11.193 | 11.485 | 10.621 | 11.872 | 8.502 | 8.475 | 7.990 | 7.977 | - | - |
| Shareholders Funds | 10.259 | 8.538 | 6.353 | 6.645 | 8.788 | 8.939 | 8.270 | 8.257 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 2.168 | 3.910 | 4.961 | 5.658 | 24 | 141 | 8 | 8 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ilomed S.r.l.